Winald R. Gerritsen
- Oncology top 0.2%
- Molecular Biology top 2%
- Immunology top 0.5%
- Surgery top 1%
- Genetics top 1%
- Co-authors
- Victor W. van BeusechemHerbert M. PinedoDavid I. QuinnI. Jolanda M. de VriesRonald de WitDean F. BajorinNicholas J. VogelzangCora N. Sternberg
- Topics
- Cancer Immunotherapy and Biomarkers (63 papers)Virus-based gene therapy research (55 papers)Immunotherapy and Immune Responses (48 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
Winald R. Gerritsen
186 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 131
- Oncology 5.4k
- Molecular Biology 3.2k
- Immunology 2.8k
- Surgery 2.2k
- Genetics 1.8k
Countries citing papers authored by Winald R. Gerritsen
This map shows the geographic impact of Winald R. Gerritsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winald R. Gerritsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winald R. Gerritsen more than expected).
Fields of papers citing papers by Winald R. Gerritsen
This network shows the impact of papers produced by Winald R. Gerritsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winald R. Gerritsen. The network helps show where Winald R. Gerritsen may publish in the future.
Co-authorship network of co-authors of Winald R. Gerritsen
This figure shows the co-authorship network connecting the top 25 collaborators of Winald R. Gerritsen. A scholar is included among the top collaborators of Winald R. Gerritsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winald R. Gerritsen. Winald R. Gerritsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 10 | |
| 3 | Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM:A Phase I Clinical Trial Including Correlative Studies | 67 |
| 4 | 15 | |
| 5 | 39 | |
| 6 | 22 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 26 | |
| 10 | 0 | |
| 11 | 6 | |
| 12 | 4 | |
| 13 | Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinomabreakdown → | 2374 |
| 14 | 5 | |
| 15 | 26 | |
| 16 | Evaluation of adenoviral oncolytic effect on glioma spheroids by 18F-DG positron-emission tomography | 2 |
| 17 | 5 | |
| 18 | 27 | |
| 19 | 52 | |
| 20 | 27 |
About Winald R. Gerritsen
Winald R. Gerritsen is a scholar working on Oncology, Immunology and Genetics, having authored 189 papers that have together received 9.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (63 papers), Virus-based gene therapy research (55 papers) and Immunotherapy and Immune Responses (48 papers). The work is most often cited by research in Oncology (5.4k citations), Immunology (2.8k citations) and Genetics (1.8k citations). Winald R. Gerritsen has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Victor W. van Beusechem, Herbert M. Pinedo, David I. Quinn, I. Jolanda M. de Vries, Ronald de Wit, Dean F. Bajorin, Nicholas J. Vogelzang, Cora N. Sternberg, Toni K. Choueiri and Yves Fradet. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.